Thuillier L, Selz F, Métézeau P, Pérignon J L
INSERM U 75 and U 132, Hôpital Necker-Enfants Malades, Paris, France.
Eur J Immunol. 1990 May;20(5):1197-200. doi: 10.1002/eji.1830200539.
We studied the effect of staurosporine, a potent inhibitor of protein kinase C (PKC) activity, on the phorbol ester- or monoclonal antibody (mAb)-induced modulation of CD3 and CD4 surface antigens. Staurosporine (10(-5) M) completely inhibited phorbol ester-induced modulation but had no effect on that induced by mAb. These results indicate that the down-regulation of CD3 and CD4 observed after activation of the cells by the corresponding mAb is independent from PKC-mediated phosphorylations, and thus that the activation of PKC is sufficient but not necessary to induce the modulation of CD3 and CD4 antigens.
我们研究了蛋白激酶C(PKC)活性的强效抑制剂星形孢菌素对佛波酯或单克隆抗体(mAb)诱导的CD3和CD4表面抗原调节的影响。星形孢菌素(10^(-5) M)完全抑制了佛波酯诱导的调节,但对mAb诱导的调节没有影响。这些结果表明,相应mAb激活细胞后观察到的CD3和CD4下调与PKC介导的磷酸化无关,因此PKC的激活足以但不是诱导CD3和CD4抗原调节所必需的。